153 related articles for article (PubMed ID: 30237365)
1. [II. Treatment Strategy for Esophagogastric Junction Tumor].
Hashimoto T; Kurokawa Y; Miyazaki Y; Takahashi T; Tanaka K; Makino T; Yamazaki M; Nakajima K; Mori M; Doki Y
Gan To Kagaku Ryoho; 2018 Sep; 45(9):1248-1253. PubMed ID: 30237365
[No Abstract] [Full Text] [Related]
2. ASO Author Reflections: Risk Factors and Prognostic Impact of Mediastinal Lymph Node Metastases in Patients with Esophagogastric Junction Cancer.
Shiraishi O
Ann Surg Oncol; 2020 Oct; 27(11):4441-4442. PubMed ID: 32451946
[No Abstract] [Full Text] [Related]
3. [Diagnosis and treatment of esophagogastric junction cancer].
Seto Y; Yamashita H
Nihon Shokakibyo Gakkai Zasshi; 2015 Oct; 112(10):1769-75. PubMed ID: 26440679
[No Abstract] [Full Text] [Related]
4. [Surgery for esophagogastric junction tumor].
Kurokawa Y; Takiguchi S; Mori M; Doki Y
Nihon Shokakibyo Gakkai Zasshi; 2015 Oct; 112(10):1785-90. PubMed ID: 26440681
[No Abstract] [Full Text] [Related]
5. Surgical and Perioperative Treatments for Esophagogastric Junction Cancer.
Yanagimoto Y; Kurokawa Y; Doki Y
Ann Thorac Cardiovasc Surg; 2024; 30(1):. PubMed ID: 38839368
[TBL] [Abstract][Full Text] [Related]
6. [A clinical case of lymph node recurrence after the resection of esophagogastric junction cancer treated by chemoradiation therapy].
Oohinata R; Iwasaki Y; Oohashi M; Iwanaga T; Takahashi K; Yamaguchi T; Matsumoto H; Nakano D
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2378-80. PubMed ID: 23268083
[TBL] [Abstract][Full Text] [Related]
7. Distribution of involved abdominal lymph nodes is correlated with the distance from the esophagogastric junction to the distal end of the tumor in Siewert type II tumors.
Mine S; Kurokawa Y; Takeuchi H; Kishi K; Ito Y; Ohi M; Matsuda T; Hamakawa T; Hasegawa S; Yoshikawa T; Hiki N
Eur J Surg Oncol; 2015 Oct; 41(10):1348-53. PubMed ID: 26087995
[TBL] [Abstract][Full Text] [Related]
8. [A case of adenosquamous carcinoma at the esophagogastric junction, initially diagnosed as collision carcinoma].
Sasaki Y; Harada M; Kurosaki S; Shimada Y; Hayashi M; Kamiichi H; Kawamura N; Kajiyama Y; Yao T
Nihon Shokakibyo Gakkai Zasshi; 2015 May; 112(5):848-55. PubMed ID: 25947020
[TBL] [Abstract][Full Text] [Related]
9. Adenocarcinoma of the esophagogastric junction: competition between Barrett and gastric cancer.
Siewert JR; Feith M
J Am Coll Surg; 2007 Oct; 205(4 Suppl):S49-53. PubMed ID: 17916519
[No Abstract] [Full Text] [Related]
10. [Treatment procedures for adenocarcinoma of the esophagogastric junction].
Moesta KT; Hünerbein M; Schlag PM
Chirurg; 2003 Apr; 74(4):381-92; quiz 392-3. PubMed ID: 12719881
[No Abstract] [Full Text] [Related]
11. Extranodal metastasis is a powerful prognostic factor in patients with adenocarcinoma of the esophagogastric junction.
Zhang HD; Tang P; Duan XF; Chen CG; Ma Z; Gao YY; Zhang H; Yu ZT
J Surg Oncol; 2013 Dec; 108(8):542-9. PubMed ID: 24018956
[TBL] [Abstract][Full Text] [Related]
12. Treatment approaches to esophagogastric junction tumors.
Kurokawa Y; Sasako M; Doki Y
Dig Surg; 2013; 30(2):169-73. PubMed ID: 23867594
[TBL] [Abstract][Full Text] [Related]
13. Extent of surgical resection for esophageal and gastroesophageal junction adenocarcinomas.
Vrouenraets BC; van Lanschot JJ
Surg Oncol Clin N Am; 2006 Oct; 15(4):781-91. PubMed ID: 17030273
[TBL] [Abstract][Full Text] [Related]
14. A Case of Alpha-Fetoprotein-Producing Adenocarcinoma of the Esophagogastric Junction in which Long-Term Survival Was Achieved by Means of Individualized Multidisciplinary Therapy.
Tanaka K; Fujiya M; Ijiri M; Takahashi K; Ando K; Nomura Y; Ueno N; Kashima S; Goto T; Sasajima J; Ito T; Moriichi K; Mizukami Y; Tanabe H; Okumura T
J Gastrointest Cancer; 2019 Sep; 50(3):617-620. PubMed ID: 29457212
[No Abstract] [Full Text] [Related]
15. Prevalence and topography of lymph node metastases in early esophageal and gastric cancer.
Gertler R; Stein HJ; Schuster T; Rondak IC; Höfler H; Feith M
Ann Surg; 2014 Jan; 259(1):96-101. PubMed ID: 24096772
[TBL] [Abstract][Full Text] [Related]
16. The prognostic relevance of parapyloric lymph node metastasis in Siewert type II/III adenocarcinoma of the esophagogastric junction.
Wang JB; Lin MQ; Li P; Xie JW; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Zheng CH; Huang CM
Eur J Surg Oncol; 2017 Dec; 43(12):2333-2340. PubMed ID: 28928013
[TBL] [Abstract][Full Text] [Related]
17. Priority of lymph node dissection for Siewert type II/III adenocarcinoma of the esophagogastric junction.
Hasegawa S; Yoshikawa T; Rino Y; Oshima T; Aoyama T; Hayashi T; Sato T; Yukawa N; Kameda Y; Sasaki T; Ono H; Tsuchida K; Cho H; Kunisaki C; Masuda M; Tsuburaya A
Ann Surg Oncol; 2013 Dec; 20(13):4252-9. PubMed ID: 23943020
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and treatment of non-metastatic esophagogastric junction adenocarcinoma: what are the current options?
Gronnier C; Piessen G; Mariette C
J Visc Surg; 2012 Feb; 149(1):e23-33. PubMed ID: 22341763
[TBL] [Abstract][Full Text] [Related]
19. Adenocarcinoma of the esophagogastric junction: surgical therapy based on 1602 consecutive resected patients.
Feith M; Stein HJ; Siewert JR
Surg Oncol Clin N Am; 2006 Oct; 15(4):751-64. PubMed ID: 17030271
[TBL] [Abstract][Full Text] [Related]
20. Optimal extent of lymph node dissection for Siewert type II esophagogastric junction carcinoma.
Yamashita H; Katai H; Morita S; Saka M; Taniguchi H; Fukagawa T
Ann Surg; 2011 Aug; 254(2):274-80. PubMed ID: 21772128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
